Literature DB >> 12553043

Anti-metastatic activities of all-trans retinoic acid, indole-3-carbinol and (+)-catechin in Dunning rat invasive prostate adenocarcinoma cells.

Joseph O Nwankwo1.   

Abstract

Dunning rat invasive prostate adenocarcinoma cells were employed to investigate the anti-metastatic potential and probable mechanisms of action of all-trans retinoic acid (ATRA), indole-3-carbinol (13C) and (+)-catechin (CAT). The invasive parameters studied include: matrigel membrane invasion; zymography and Northern analysis for matrix metalloproteinases (MMPs) activity and gene expression; and Western analysis for the membrane-associated proteins alpha-, beta- and gamma-catenins. ATRA significantly and dose-dependently inhibited matrigel membrane invasion of the cells by 53%, inhibited MMP-2 activity by 71%, MMP-9(80%), alpha-(59%) and beta-(65%) catenin expression at 10 microM (p < 0.01). gamma-Catenin expression was completely inhibited by ATRA even at 2 microM. Catechin at 25 microM decreased matrigel membrane invasion by 24% and also inhibited gamma-catenin protein levels by 58% (p < 0.01). Loss of E-cadherin was implicated in the exacerbation of the anti-metastatic effects of ATRA and CAT by the use of E-cadherin-positive, non-invasive cells. In conclusion, ATRA and CAT show anti-metastatic potential in the invasive rat prostate adenocarcinoma model and gamma-catenin appears to play a mechanistic role.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12553043

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells.

Authors:  Yasunari Takada; Michael Andreeff; Bharat B Aggarwal
Journal:  Blood       Date:  2005-04-05       Impact factor: 22.113

Review 2.  Role of retinoids in the prevention and treatment of colorectal cancer.

Authors:  Catherine C Applegate; Michelle A Lane
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

3.  Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells: biological correlates and molecular targets.

Authors:  Mineko Terao; Maddalena Fratelli; Mami Kurosaki; Adriana Zanetti; Valeria Guarnaccia; Gabriela Paroni; Anna Tsykin; Monica Lupi; Maurizio Gianni; Gregory J Goodall; Enrico Garattini
Journal:  J Biol Chem       Date:  2010-12-03       Impact factor: 5.157

4.  Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression.

Authors:  Floriana Centritto; Gabriela Paroni; Marco Bolis; Silvio Ken Garattini; Mami Kurosaki; Maria Monica Barzago; Adriana Zanetti; James Neil Fisher; Mark Francis Scott; Linda Pattini; Monica Lupi; Paolo Ubezio; Francesca Piccotti; Alberto Zambelli; Paola Rizzo; Maurizio Gianni'; Maddalena Fratelli; Mineko Terao; Enrico Garattini
Journal:  EMBO Mol Med       Date:  2015-07       Impact factor: 12.137

5.  Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXN.

Authors:  E E Oldridge; H F Walker; M J Stower; M S Simms; V M Mann; A T Collins; D Pellacani; N J Maitland
Journal:  Oncogenesis       Date:  2013-04-15       Impact factor: 7.485

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.